ULH CORP

Specializing in Services-Medical Laboratories under SIC 8071, ULH CORP positions itself as a dependable provider of comprehensive diagnostic testing and analytical services that support hospital systems, physician practices, and clinical researchers who demand fast, accurate lab results for patient care and trial workflows. The company’s platform combines specimen processing, high-complexity testing, and ancillary laboratory management consulting to help healthcare partners navigate the accelerating volume of routine and specialized assays, while emerging regulatory scrutiny around data integrity, patient privacy, and the evolving reimbursement landscape requires ULH to allocate resources toward compliance, workforce training, and ongoing technology upgrades. Investors tracking this legacy player note that its most recent Form 10-Q filed April 1999 remains the latest public snapshot of operations, underscoring both a conservative disclosure cadence and the obligation to stay current with SEC requirements as a reporting entity; CIK 354199 serves as the reference point for that history. See live SEC filings on Earnings Feed to follow updates.

Source: Earnings Feed research · last updated 11/24/2025